Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
ID: PAR-21-340 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 9/17/21 the National Institutes of Health posted grant opportunity PAR-21-340 for Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed).
The grant will be issued under grant program 93.350 National Center for Advancing Translational Sciences.
Timing
Posted Date
Sept. 17, 2021, 12:00 a.m. EDT
Closing Date
Nov. 7, 2023, 12:00 a.m. EST Past Due
Last Updated
Nov. 7, 2023, 1:08 p.m. EST
Version
2
Archive Date
Dec. 7, 2023
Eligibility
Eligible Applicants
Public and State controlled institutions of higher education
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See the Funding Announcement for Full Eligibility Details
Award Sizing
Ceiling
$500,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information Site
Documents
Posted documents for PAR-21-340
Opportunity Assistant
AI Analysis
AI Generate